The mutation profile of primary tumor, liver metastatic site, and plasma ctDNA of a metastatic ER+/HER2+ BC patient was studied by WES (166): The primary tumor was biopsied 4 months after neoadjuvant chemotherapy. This evidence concerns the gene ESR1 and neoplasm.